bioMérieux
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
BIM | PA
Overview
Corporate Details
- ISIN(s):
- FR0013280286 (+13 more)
- LEI:
- 549300AK8Y0LBIQ4T071
- Country:
- France
- Address:
- 376 CHE DE L'ORME, 69280 MARCY-L'ETOILE
- Website:
- https://www.biomerieux.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
bioMérieux is a global leader in the field of in vitro diagnostics, dedicated to improving public health worldwide. Since its founding in 1963, the company has developed and provided comprehensive diagnostic solutions—including systems, reagents, software, and services—that enable critical decision-making for clinicians and industrial quality control professionals. The company's activities are focused on two primary areas: clinical diagnostics and industrial microbiology. In the clinical market, its solutions support the diagnosis of infectious diseases, management of sepsis, cardiovascular emergencies, and antimicrobial stewardship. For industrial applications, bioMérieux offers microbiological testing solutions to ensure the safety and quality of food, pharmaceutical, and cosmetic products. The portfolio features advanced systems like BIOFIRE® (multiplex PCR), VITEK® (microbial identification), and BACT/ALERT® (automated blood culture) to deliver rapid and reliable results.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-02 11:11 |
Declaration of Voting Results & Voting Rights Announcements
Août 2025 - Déclaration sur le nombre d'actions composant le capital social et …
|
French | 106.1 KB | ||
| 2025-08-05 09:41 |
Declaration of Voting Results & Voting Rights Announcements
Juillet 2025 - Déclaration sur le nombre d'actions composant le capital social …
|
French | 105.8 KB | ||
| 2025-06-16 07:01 |
M&A Activity
bioMérieux strengthens its next-generation sequencing capabilities with the acq…
|
English | 222.9 KB | ||
| 2025-06-16 07:01 |
M&A Activity
bioMérieux renforce ses capacités de séquençage de nouvelle génération avec l’a…
|
French | 248.3 KB | ||
| 2025-06-03 16:05 |
Declaration of Voting Results & Voting Rights Announcements
Mai 2025 - Déclaration sur le nombre d'actions composant le capital social et s…
|
French | 106.1 KB | ||
| 2025-06-03 07:01 |
Environmental & Social Information
bioMérieux launches cutting-edge equine infectious respiratory disease testing
|
English | 276.4 KB | ||
| 2025-06-03 07:01 |
Regulatory News Service
bioMérieux lance un test diagnostic innovant pour détecter les maladies respira…
|
French | 274.0 KB | ||
| 2025-05-05 11:37 |
Declaration of Voting Results & Voting Rights Announcements
Avril 2025 - Déclaration sur le nombre d'actions composant le capital social et…
|
French | 106.1 KB | ||
| 2025-04-22 07:01 |
Environmental & Social Information
WATCHFIRE™ by bioMérieux: a PCR test to detect viruses and bacteria in wastewat…
|
English | 277.8 KB | ||
| 2025-04-22 07:01 |
Regulatory News Service
WATCHFIRE™, un nouveau test PCR développé par bioMérieux pour détecter les viru…
|
French | 267.8 KB | ||
| 2025-04-17 07:01 |
Investor Presentation
bioMérieux – First-Quarter 2025 Business Review
|
English | 325.6 KB | ||
| 2025-04-17 07:01 |
Earnings Release
bioMérieux – Information financière du 1er trimestre 2025
|
French | 281.7 KB | ||
| 2025-04-07 07:01 |
Regulatory News Service
bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solutio…
|
English | 276.6 KB | ||
| 2025-04-07 07:01 |
Business and Financial Review
bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de…
|
French | 262.7 KB | ||
| 2025-04-02 14:13 |
Declaration of Voting Results & Voting Rights Announcements
Mars 2025 - Déclaration sur le nombre d'actions composant le capital social et …
|
French | 106.1 KB |
Automate Your Workflow. Get a real-time feed of all bioMérieux filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for bioMérieux via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-04 | N/A | Other | Sell | 1,432 | 137,517.82 EUR |
| 2023-09-04 | N/A | Other | Sell | 1,253 | 120,328.10 EUR |
| 2023-09-01 | N/A | Other | Other | 2,900 | N/A |
| 2023-06-23 | N/A | Other | Other | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 300 | 23,193.00 EUR |
| 2023-06-23 | N/A | Other | Buy | 25 | 1,932.75 EUR |
| 2023-03-23 | N/A | Other | Sell | 16,500 | 1,650,415.80 EUR |
